113 related articles for article (PubMed ID: 2168279)
1. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
Del Bino G; Skierski JS; Darzynkiewicz Z
Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279
[TBL] [Abstract][Full Text] [Related]
2. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
Del Bino G; Darzynkiewicz Z
Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
[TBL] [Abstract][Full Text] [Related]
5. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z
Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962
[TBL] [Abstract][Full Text] [Related]
6. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
[TBL] [Abstract][Full Text] [Related]
7. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
Gong J; Li X; Darzynkiewicz Z
J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159
[TBL] [Abstract][Full Text] [Related]
9. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
Gong J; Traganos F; Darzynkiewicz Z
Cancer Res; 1993 Nov; 53(21):5096-9. PubMed ID: 8221643
[TBL] [Abstract][Full Text] [Related]
11. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
Kaufmann SH
Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.
Bruno S; Lassota P; Giaretti W; Darzynkiewicz Z
Oncol Res; 1992; 4(1):29-35. PubMed ID: 1374671
[TBL] [Abstract][Full Text] [Related]
13. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
Del Bino G; Bruno S; Yi PN; Darzynkiewicz Z
Cell Prolif; 1992 Nov; 25(6):537-48. PubMed ID: 1333822
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK
Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614
[TBL] [Abstract][Full Text] [Related]
16. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
Bruno S; Giaretti W; Darzynkiewicz Z
J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
18. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
[TBL] [Abstract][Full Text] [Related]
19. Effects of topoisomerase I inhibition on the expression of topoisomerase II alpha measured with fluorescence image cytometry.
Nicklee T; Crump M; Hedley DW
Cytometry; 1996 Nov; 25(3):205-10. PubMed ID: 8914817
[TBL] [Abstract][Full Text] [Related]
20. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
Hsiang YH; Lihou MG; Liu LF
Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
